WHWK
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ · Healthcare
Whitehawk Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Whitehawk Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Whitehawk Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 7.1 M, a 71.08% decrease year-over-year.
- Whitehawk Therapeutics, Inc. annual revenue for 2025 was 7.1 M, a 72.50% decrease from 2024.
- Whitehawk Therapeutics, Inc. annual revenue for 2024 was 26.0 M, a 6.69% increase from 2023.
- Whitehawk Therapeutics, Inc. annual revenue for 2023 was 24.4 M, a 60.06% increase from 2022.
- Whitehawk Therapeutics, Inc. annual revenue for 2022 was 15.2 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Whitehawk Therapeutics, Inc. Earnings — FAQ
Whitehawk Therapeutics, Inc. (WHWK) earnings over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WHWK's earnings history?
The chart and table above show Whitehawk Therapeutics, Inc.'s earnings by year and by quarter, including the growth rate.